Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Taghi Mostafavi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
IEEE/ACM Transactions on Computational Biology and Bioinformatics|March 26, 2019
Causal Disturbance Analysis: A Novel Graph Centrality Based Method for Pathway Enrichment AnalysisPourya Naderi Yeganeh, M Taghi Mostafavi
Biodata Mining|June 19, 2020
Revisiting the use of graph centrality models in biological pathway analysisPourya Naderi Yeganeh, Chrsitine Richardson, Erik Saule, et al.
Genes & Cancer|January 12, 2018
Dysregulation of AKT3 along with a small panel of mRNAs stratifies high-grade serous ovarian cancer from both normal epithelia and benign tumor tissuesPourya Naderi Yeganeh, Christine Richardson, Zahra Bahrani-Mostafavi, et al.
Cancer Investigation|June 6, 2015
Downregulation of HOXC6 in Serous Ovarian CancerDavid L Tait, Zahra Bahrani-Mostafavi, C Greer Vestal, et al.
Cancer Investigation|December 19, 2008
Correlation analysis of HOX, ErbB and IGFBP family gene expression in ovarian cancerZahra Bahrani-Mostafavi, Timothy L Tickle, Jian Zhang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
IEEE/ACM Transactions on Computational Biology and Bioinformatics|March 26, 2019
Causal Disturbance Analysis: A Novel Graph Centrality Based Method for Pathway Enrichment AnalysisPourya Naderi Yeganeh, M Taghi Mostafavi
Biodata Mining|June 19, 2020
Revisiting the use of graph centrality models in biological pathway analysisPourya Naderi Yeganeh, Chrsitine Richardson, Erik Saule, et al.
Genes & Cancer|January 12, 2018
Dysregulation of AKT3 along with a small panel of mRNAs stratifies high-grade serous ovarian cancer from both normal epithelia and benign tumor tissuesPourya Naderi Yeganeh, Christine Richardson, Zahra Bahrani-Mostafavi, et al.
Cancer Investigation|June 6, 2015
Downregulation of HOXC6 in Serous Ovarian CancerDavid L Tait, Zahra Bahrani-Mostafavi, C Greer Vestal, et al.
Cancer Investigation|December 19, 2008
Correlation analysis of HOX, ErbB and IGFBP family gene expression in ovarian cancerZahra Bahrani-Mostafavi, Timothy L Tickle, Jian Zhang, et al.
Pageof 1